Stay updated on Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page
- Check4 days agoChange DetectedA notice announces NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence” and links to related updates and FAQs.SummaryDifference0.3%

- Check11 days agoChange DetectedThe clinical trial record has a new version reflecting updates to its study status and contacts/locations.SummaryDifference0.3%

- Check18 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1; the study record content is otherwise unchanged.SummaryDifference0.0%

- Check39 days agoChange DetectedThe history now includes the latest Revision: v3.7.0 entry and removes the previous Revision: v3.6.6 entry.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6 in the footer, indicating a new version entry in the history.SummaryDifference0.0%

- Check81 days agoChange DetectedFooter revision updated from v3.6.4 to v3.6.5, indicating a new page version. This reflects a routine maintenance update to the page metadata rather than content changes.SummaryDifference0.0%

Stay in the know with updates to Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.